BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19067729)

  • 1. When should genetic testing be obtained in a patient with phaeochromocytoma or paraganglioma?
    Erlic Z; Neumann HP
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):354-7. PubMed ID: 19067729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic testing in pheochromocytoma or functional paraganglioma.
    Amar L; Bertherat J; Baudin E; Ajzenberg C; Bressac-de Paillerets B; Chabre O; Chamontin B; Delemer B; Giraud S; Murat A; Niccoli-Sire P; Richard S; Rohmer V; Sadoul JL; Strompf L; Schlumberger M; Bertagna X; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP
    J Clin Oncol; 2005 Dec; 23(34):8812-8. PubMed ID: 16314641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea.
    Kim JH; Seong MW; Lee KE; Choi HJ; Ku EJ; Bae JH; Park SS; Choi SH; Kim SW; Shin C; Kim SY
    Clin Genet; 2014 Nov; 86(5):482-6. PubMed ID: 24134185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationalization of genetic testing in patients with apparently sporadic pheochromocytoma/paraganglioma.
    Cascón A; López-Jiménez E; Landa I; Leskelä S; Leandro-García LJ; Maliszewska A; Letón R; de la Vega L; García-Barcina MJ; Sanabria C; Alvarez-Escolá C; Rodríguez-Antona C; Robledo M
    Horm Metab Res; 2009 Sep; 41(9):672-5. PubMed ID: 19343621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Germline gene testing of the RET, VHL, SDHD and SDHB genes in patients with pheochromocytoma/paraganglioma].
    Wu K; Zhang Y; Zhang H; Tan ZH; Guo XH; Yang JM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 50(4):634-639. PubMed ID: 30122763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetics of phaeochromocytoma: using clinical features to guide genetic testing.
    Jafri M; Maher ER
    Eur J Endocrinol; 2012 Feb; 166(2):151-8. PubMed ID: 21896620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of pheochromocytoma and paraganglioma in Spanish pediatric patients.
    Cascón A; Inglada-Pérez L; Comino-Méndez I; de Cubas AA; Letón R; Mora J; Marazuela M; Galofré JC; Quesada-Charneco M; Robledo M
    Endocr Relat Cancer; 2013 Jun; 20(3):L1-6. PubMed ID: 23404858
    [No Abstract]   [Full Text] [Related]  

  • 8. A comprehensive next generation sequencing-based genetic testing strategy to improve diagnosis of inherited pheochromocytoma and paraganglioma.
    Rattenberry E; Vialard L; Yeung A; Bair H; McKay K; Jafri M; Canham N; Cole TR; Denes J; Hodgson SV; Irving R; Izatt L; Korbonits M; Kumar AV; Lalloo F; Morrison PJ; Woodward ER; Macdonald F; Wallis Y; Maher ER
    J Clin Endocrinol Metab; 2013 Jul; 98(7):E1248-56. PubMed ID: 23666964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma.
    Jafri M; Whitworth J; Rattenberry E; Vialard L; Kilby G; Kumar AV; Izatt L; Lalloo F; Brennan P; Cook J; Morrison PJ; Canham N; Armstrong R; Brewer C; Tomkins S; Donaldson A; Barwell J; Cole TR; Atkinson AB; Aylwin S; Ball SG; Srirangalingam U; Chew SL; Evans DG; Hodgson SV; Irving R; Woodward E; Macdonald F; Maher ER
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):898-906. PubMed ID: 23072324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma.
    Korpershoek E; Petri BJ; van Nederveen FH; Dinjens WN; Verhofstad AA; de Herder WW; Schmid S; Perren A; Komminoth P; de Krijger RR
    Endocr Relat Cancer; 2007 Jun; 14(2):453-62. PubMed ID: 17639058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preoperative genetic diagnostics and imaging for pediatric pheochromocytoma and paraganglioma].
    Dralle H
    Chirurg; 2017 Jul; 88(7):618. PubMed ID: 28616677
    [No Abstract]   [Full Text] [Related]  

  • 12. Childhood phaeochromocytoma and paraganglioma: 100% incidence of genetic mutations and 100% survival.
    Hammond PJ; Murphy D; Carachi R; Davidson DF; McIntosh D
    J Pediatr Surg; 2010 Feb; 45(2):383-6. PubMed ID: 20152357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the genetics of phaeochromocytoma and functional paraganglioma.
    Gimenez-Roqueplo AP; Burnichon N; Amar L; Favier J; Jeunemaitre X; Plouin PF
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):376-9. PubMed ID: 18307724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma.
    Cascon A; Ruiz-Llorente S; Cebrian A; Telleria D; Rivero JC; Diez JJ; Lopez-Ibarra PJ; Jaunsolo MA; Benitez J; Robledo M
    Eur J Hum Genet; 2002 Aug; 10(8):457-61. PubMed ID: 12111639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phaeochromocytoma, new genes and screening strategies.
    Gimenez-Roqueplo AP; Lehnert H; Mannelli M; Neumann H; Opocher G; Maher ER; Plouin PF;
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):699-705. PubMed ID: 17121518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients.
    Currás-Freixes M; Inglada-Pérez L; Mancikova V; Montero-Conde C; Letón R; Comino-Méndez I; Apellániz-Ruiz M; Sánchez-Barroso L; Aguirre Sánchez-Covisa M; Alcázar V; Aller J; Álvarez-Escolá C; Andía-Melero VM; Azriel-Mira S; Calatayud-Gutiérrez M; Díaz JÁ; Díez-Hernández A; Lamas-Oliveira C; Marazuela M; Matias-Guiu X; Meoro-Avilés A; Patiño-García A; Pedrinaci S; Riesco-Eizaguirre G; Sábado-Álvarez C; Sáez-Villaverde R; Sainz de Los Terreros A; Sanz Guadarrama Ó; Sastre-Marcos J; Scolá-Yurrita B; Segura-Huerta Á; Serrano-Corredor Mde L; Villar-Vicente MR; Rodríguez-Antona C; Korpershoek E; Cascón A; Robledo M
    J Med Genet; 2015 Oct; 52(10):647-56. PubMed ID: 26269449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor.
    Elder EE; Elder G; Larsson C
    J Surg Oncol; 2005 Mar; 89(3):193-201. PubMed ID: 15719371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The approach to the patient with paraganglioma.
    Neumann HP; Eng C
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2677-83. PubMed ID: 19657044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetics of paragangliomas and pheochromocytomas].
    Favier J; Gimenez-Roqueplo AP
    Med Sci (Paris); 2012; 28(6-7):625-32. PubMed ID: 22805139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pheo-Type: A Diagnostic Gene-expression Assay for the Classification of Pheochromocytoma and Paraganglioma.
    Flynn A; Dwight T; Harris J; Benn D; Zhou L; Hogg A; Catchpoole D; James P; Duncan EL; Trainer A; Gill AJ; Clifton-Bligh R; Hicks RJ; Tothill RW
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1034-43. PubMed ID: 26796762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.